A Rare but Morbid Occurrence: Development of Glioblastoma Multiforme During Tumor Necrosis Factor Inhibitor Therapy

The use of biologic therapies continues to become more prevalent in the treatment of inflammatory bowel disease, particularly for more severe disease. Although generally safe and effective, specific biologic classes such as tumor necrosis factor inhibitor (anti-TNF) medications are known to increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraemer, Laura S, Humes, Ross J, Syed, Azfar S, Tritsch, Adam M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199570/
https://www.ncbi.nlm.nih.gov/pubmed/35719803
http://dx.doi.org/10.7759/cureus.25027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199570/
https://www.ncbi.nlm.nih.gov/pubmed/35719803
http://dx.doi.org/10.7759/cureus.25027

Ejemplares similares